Application RelevanceSupport assessment: Medium
Compound 1 also shows anticancer activity, with the strongest reported MTT response against MDA-MB-231 cells among the tested cancer cell lines.
Caveat: Biological assay protocols are in the SI and are outside the core conductive-MOF transport focus.
rendered page 5 / article p.19941 · Cytotoxicity Studies · Figure 10 · Linked to 4 structured results
Phase AssignmentSupport assessment: High
Compound 1 is assigned as a crystalline Zn(II) coordination framework with tdc2- and pcih bridges; local 2D rectangular sheets are extended into a 3D architecture by pcih bridging and supramolecular interactions.
Caveat: SI crystallographic tables were supplied, but the CIF/CCDC data file itself was not local.
rendered pages 2-3 / article pp.19938-19939 · Crystal Structure · Figures 1-2 · Linked to 3 structured results
Structure Property LinkSupport assessment: Medium
SCLC analysis indicates higher effective mobility and diffusion length under illumination, supporting improved charge-transfer kinetics in the light phase.
Caveat: The SI supplies the capacitance-frequency plot and equations, but dielectric constant is inconsistent between main-text prose/SI prose and Table 2.
rendered pages 5-6 / article pp.19941-19942 · Optical and Electrical Characterization · Table 2 · Linked to 6 structured results
Transport MechanismSupport assessment: High
Compound 1 behaves as a semiconducting MS-junction material whose conductivity and Schottky parameters improve under illumination.
Caveat: SI provides device fabrication details and equations, but the metal top-electrode identity is inconsistent between Al/gold wording.
rendered pages 3-5 / article pp.19939-19941 · Optical and Electrical Characterization · Figure 5; Table 1 · Linked to 7 structured results